Table 3.
Onset of Bone Formation in Orthotopic (Ulnar) Constructs
| Condition | Calcein Green week-3 label | Tetracycline week-5 label | Xylenol Orange week-7 label |
|---|---|---|---|
| Within scaffold | |||
| BMPs/VEGFf | 6/8 | 8/8 | 8/8 |
| BMPf/VEGFs | 8/8 | 8/8 | 8/8 |
| Control | 2/4 | 3/4 | 3/4 |
| Central canal | |||
| BMPs/VEGFf | 1/8 | 7/8 | 7/8 |
| BMPf/VEGFs | 1/8 | 8/8 | 8/8 |
| Control | 1/4 | 2/4 | 2/4 |
| Outside scaffold | |||
| BMPs/VEGFf | 8/8 | 8/8 | 8/8 |
| BMPf/VEGFs | 8/8 | 8/8 | 8/8 |
| Control | 4/4 | 4/4 | 4/4 |
Incorporation of fluorochrome labels at weeks 3, 5, and 7, presence scored per implant.